SoloHealth announced today its new pay-per-performance ad format – SoloTrigger. The permission-based advertising format delivers targeted sponsor content that allows consumers to actively request additional information regarding products or services, the company said in the announcement.
During a limited three-day trial, close to 11,000 of the 69,000 consumers that interacted with the SoloHealth Station kiosk requested additional information via the SoloTrigger ad format, representing 16 percent of the total audience. Based on these initial trials, the company said that an execution across SoloHealth's nationwide footprint would yield results of more than a 500,000 engaged consumers actively seeking more information on products and/or services during the course of 30 days. Sponsors only pay when consumers actively engage with the ad content.
The Stations are currently located in more than 1,200 retail locations nationwide, including Sam's Club and Walmart stores, expanding to more than 2,500 store locations by mid-2013 and 4,000 by 2014, the announcement said. SoloHealth's inaugural advertising partners include Johnson & Johnson, P&G, Pfizer, Bayer, Hallmark and The Coca-Cola Company.
"Targeted and contextually relevant content is what today's savvy consumers expect, and brands must meet those expectations to build engaged interactions that drive change in behavior," said Dan Bonert, VP of advertising sales for SoloHealth. "Our national platform allows brands to become solutions for consumers, providing a meaningful experience with their content and an opportunity to reach health-conscious shoppers when they are engaged and interested in products that are aisles away, not miles away."
Read more about kiosks in health care.